Clozapine Tablets

This product is a dibenzodiazepine antipsychotic. It has a strong blocking effect on the 5-hydroxytryptamine (5-HT2A) receptor and dopamine (DA1) receptor in the brain, and also has a blocking effect on the dopamine (DA4) receptor, and a weaker blocking effect on the dopamine (DA2) receptor. In addition, it has anticholinergic (M1), antihistamine (H1) and anti-α-adrenaline receptor effects, and rarely has extrapyramidal reactions. It generally does not cause an increase in blood prolactin. It can directly inhibit the ascending activation system of the brainstem reticular formation and has a strong sedative and hypnotic effect.

The main ingredient of this product is clozapine, and its chemical name is: 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine.

This product is light yellow tablet.

This product is not only effective for positive symptoms of psychosis, but also has a certain effect on negative symptoms. It is suitable for various subtypes of acute and chronic schizophrenia, and has good effects on hallucination and delusional types and adolescent types. It can also alleviate the emotional symptoms related to schizophrenia (such as depression, guilt, and anxiety). For some patients who are ineffective or have poor treatment effects with traditional antipsychotic drugs, switching to this product may be effective. This product is also used to treat excitement, agitation, hallucinations and delusions in mania or other psychotic disorders. Because it causes neutropenia, it is generally not suitable as the first choice drug.

Oral administration starts with a small dose, the first dose is 25 mg once, 2 to 3 times a day, and gradually increases to the commonly used therapeutic dose of 200 to 400 mg a day, and the highest dose can reach 600 mg a day. The maintenance dose is 100 to 200 mg a day.

1. Strong sedative effect and anticholinergic adverse reactions are common, including dizziness, weakness, drowsiness, sweating, salivation, nausea, vomiting, dry mouth, constipation, postural hypotension, and tachycardia. 2. Common increased appetite and weight gain. 3. Can cause abnormal changes in electrocardiogram. Can cause changes in electroencephalogram or epileptic seizures. 4. Can also cause increased blood sugar. 5. Serious adverse reactions are agranulocytosis and secondary infection.

It is contraindicated for patients with severe heart, liver, or kidney disease, coma, delirium, hypotension, epilepsy, glaucoma, bone marrow suppression, or leukopenia. It is contraindicated for patients who are allergic to this product.

Precautions for children: Not suitable for children under 12 years old. Precautions for pregnancy and lactation: Contraindicated for pregnant women. Lactating women should stop breastfeeding while using this product. Precautions for the elderly: Use with caution or use low doses.

1. The combination of this product with ethanol or other central nervous system depressants can increase the central inhibitory effect. 2. The combination of this product with antihypertensive drugs has the risk of increasing postural hypotension. 3. The combination of this product with anticholinergic drugs can increase the anticholinergic effect. 4. The combination of this product with digoxin, heparin, phenytoin, and warfarin can aggravate the bone marrow suppression effect. 5. The combination of this product with lithium carbonate has the risk of increasing convulsions, malignant syndrome, delirium and dystonia. 6. The combination of this product with antidepressants such as fluvoxamine, fluoxetine, paroxetine, and sertraline can increase the plasma levels of clozapine and norclozapine. 7. The combination of this product with macrolide antibiotics can significantly increase the plasma concentration of clozapine, and there are reports of inducing epileptic seizures.

Keep away from light and store in sealed container.

25mg

24 months

Guangdong P.D.Pharmaceutical Co., Ltd.

• Founded in:

  1994-08-15

• Address:

  No. 66, Bidi Avenue, Yueshan Town, Kaiping City, Guangdong Province

• Tax NO.:

  91440700617754849P

• Registered Funds:

  $6 million

• Website:

  Log in to view

• Email:

  Log in to view